The DOI matches its Crossref record; 316 of the 316 references it cites were found in a registry or an index.
Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Open accessAbstract
Cells require tight regulation of the intracellular redox balance and consequently of reactive oxygen species for proper redox signaling and maintenance of metal (e.g., of iron and copper) homeostasis. In several diseases, including cancer, this balance is disturbed. Therefore, anticancer drugs targeting the redox systems, for example, glutathione and thioredoxin, have entered focus of interest. Anticancer metal complexes (platinum, gold, arsenic, ruthenium, rhodium, copper, vanadium, cobalt, manganese, gadolinium, and molybdenum) have been shown to strongly interact with or even disturb cellular redox homeostasis. In this context, especially the hypothesis of "activation by reduction" as well as the "hard and soft acids and bases" theory with respect to coordination of metal ions to cellular ligands represent important concepts to understand the molecular modes of action of anticancer metal drugs. The aim of this review is to highlight specific interactions of metal-based anticancer drugs with the cellular redox homeostasis and to explain this behavior by considering chemical properties of the respective anticancer metal complexes currently either in (pre)clinical development or in daily clinical routine in oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–316 of 316
Are peroxiredoxins tumor suppressors?
Neumann, C. A., & Fang, Q. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.007 · Cited by 133
Cullen, K. J., Newkirk, K. A., Schumaker, L. M., Aldosari, N., Rone, J. D., & Haddad, B. R. (2003) · PubMed · Cited by 133
Lo, Y., Ko, T., Su, W., Su, T., & Wang, A. H. ‐. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.05.006 · Cited by 130
Moriya, M., Ho, Y., Grana, A., Nguyen, L., Alvarez, A., Jamil, R., Ackland, M. L., Michalczyk, A. A., Hamer, P., Ramos, D., et al. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00029.2008 · Cited by 130
Liochev, S. I. (2018) · Routledge eBooks · doi:10.1201/9780203747605-1 · Cited by 129
1H, 13C‐NMR and X‐ray Absorption Studies of Copper(I) Glutathione Complexes
Corazza, A., Harvey, I., & Sadler, P. J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0697d.x · Cited by 127
Sasada, T., Nakamura, H., Ueda, S., Sato, N., Kitaoka, Y., Gon, Y., Takabayashi, A., Spyrou, G., Holmgren, A., & Yodoi, J. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00101-x · Cited by 126
Auranofin blocks interleukin‐6 signalling by inhibiting phosphorylation of JAK1 and STAT3
Kim, N.-H., Lee, M.-Y., Park, S.-J., Choi, J.-S., Oh, M.-K., & Kim, I.-S. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02679.x · Cited by 125
Vergara, E., Casini, A., Sorrentino, F., Zava, O., Cerrada, E., Rigobello, M. P., Bindoli, A., Laguna, M., & Dyson, P. J. (2009) · ChemMedChem · doi:10.1002/cmdc.200900370 · Cited by 125
Waters, S. B., Devesa, V., Razo, L. M. D., Stýblo, M., & Thomas, D. J. (2004) · Chemical Research in Toxicology · doi:10.1021/tx0342161 · Cited by 122
From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling
Morinville, A., Maysinger, D., & Shaver, A. G. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01257-7 · Cited by 121
Hancock, C. N., Stockwin, L. H., Han, B., Divelbiss, R. D., Jun, J. H., Malhotra, S. V., Hollingshead, M. G., & Newton, D. L. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.696 · Cited by 120
Kapitza, S. B., Jakupec, M. A., Uhl, M., Keppler, B. K., & Marian, B. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.002 · Cited by 119
Self-citationNa, H., & Surh, Y. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20225 · Cited by 116
Mellish, K. J., Kèlland, L. R., & Harrap, K. R. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.322 · Cited by 115
Batinic̈‐Haberle, I., Spasojević, I., Tse, H. M., Tovmasyan, A. G., Rajić, Z., Clair, D. K. S., Vujašković, Ž., Dewhirst, M. W., & Piganelli, J. D. (2010) · Amino Acids · doi:10.1007/s00726-010-0603-6 · Cited by 114
Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity
Hellberg, V., Wallin, I., Eriksson, S., Hernlund, E., Jerremalm, E., Berndtsson, M., Eksborg, S., Arnér, E. S. J., Shoshan, M. C., Ehrsson, H., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn418 · Cited by 113
Reduction ofcis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by Aqueous Extracts of Cancer Cells
Nemirovski, A., Kasherman, Y., Ardeli‐Tzaraf, Y., & Gibson, D. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070740j · Cited by 113
The role of the transferrin–transferrin-receptor system in drug delivery and targeting
Li, H., Sun, H., & Qian, Z. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)01989-2 · Cited by 111
Zhang, X., Frezza, M., Milacic, V., Ronconi, L., Fan, Y., Bi, C., Fregona, D., & Dou, Q. P. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22394 · Cited by 111
Shi, X., Jiang, H., Mao, Y., Ye, J., & Saffiotti, U. (1996) · Toxicology · doi:10.1016/0300-483x(95)03151-5 · Cited by 107
Tsang, S. Y., Tam, S. C., Bremner, I., & Burkitt, M. J. (1996) · Biochemical Journal · doi:10.1042/bj3170013 · Cited by 107
Rabbani, Z. N., Spasojević, I., Zhang, X., Moeller, B. J., Haberle, S., Vasquez-Vivar, J. M., Dewhirst, M. W., Vujašković, Ž., & Batinic̈‐Haberle, I. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.001 · Cited by 105
Shi, T., Berglund, J., & Elding, L. I. (1996) · Inorganic Chemistry · doi:10.1021/ic951598s · Cited by 103
Aguirre, J. D., Angeles-Boza, A. M., Chouai, A., Pellois, J., Turró, C., & Dunbar, K. R. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9021717 · Cited by 103
Kim, H.-J., Son, H., Bailey, S. M., & Lee, J. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90632.2008 · Cited by 102
Glutathione-mediated activation of anticancer platinum(IV) complexes
Eastman, A. R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90581-8 · Cited by 101
Ray, R. S., Ghosh, B., Rana, A., & Chatterjee, M. (2006) · International Journal of Cancer · doi:10.1002/ijc.22277 · Cited by 101
Hypoxia-Activated Prodrugs in Cancer Therapy: Progress to the Clinic
Denny, W. A. (2010) · Future Oncology · doi:10.2217/fon.10.1 · Cited by 100
Surowiak, P., Materna, V., Kaplenko, I., Spaczyński, M., Dietel, M., Lage, H., & Zabel, M. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-1228-0 · Cited by 98
Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4
Youn, H. S., Lee, J. Y., Saitoh, S. I., Miyake, K., & Hwang, D. H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.097 · Cited by 94
Ceruloplasmin/Transferrin System Is Related to Clinical Status in Acute Stroke
Altamura, C., Squitti, R., Pasqualetti, P., Gaudino, C., Palazzo, P., Tibuzzi, F., Lupoi, D., Cortesi, M., Rossini, P. M., & Vernieri, F. (2009) · Stroke · doi:10.1161/strokeaha.108.536714 · Cited by 94
Cisplatin Cytotoxicity: DNA and Plasma Membrane Targets
Rébillard, A., Lagadic‐Gossmann, D., & Dimanche‐Boitrel, M. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242903 · Cited by 94
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
Morbidelli, L., Donnini, S., Filippi, S., Luigi Messori, A., Piccioli, F., Orioli, P., Sava, G., & Ziche, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600906 · Cited by 92
p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA
Hedström, E., Eriksson, S. E., Zawacka‐Pankau, J., Arnér, E. S. J., & Selivanova, G. (2009) · Cell Cycle · doi:10.4161/cc.8.21.9977 · Cited by 92
Han, Y. H., Kim, S. Z., Kim, S. H., & Park, W. H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.041 · Cited by 91
A Phase II Trial of Tetrathiomolybdate After Surgery for Malignant Mesothelioma: Final Results
Pass, H. I., Brewer, G. J., Dick, R., Carbone, M., & Merajver, S. D. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.03.016 · Cited by 90
Chowdhury, U. K., ZAKHARYAN, R., Hernández, A., Avram, M. J., Kopplin, M., & Aposhian, H. V. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.06.014 · Cited by 88
Kamalakannan, P., & Venkappayya, D. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00413-0 · Cited by 87
Trigona, W. L., Kanevsky, I., Cao, Y.-Z., & Sordillo, L. M. (2006) · Biochemical Journal · doi:10.1042/bj20050712 · Cited by 86
Sánchez, Y., Amrán, D., Fernández, C., de Blas, E., & Aller, P. (2008) · International Journal of Cancer · doi:10.1002/ijc.23639 · Cited by 85
Piccioli, F., Sabatini, S., Luigi Messori, A., Orioli, P., Hartinger, C. G., & Keppler, B. K. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.04.002 · Cited by 83
Self-citationGourdier, I., Crabbé, L., Andréau, K., Pau, B., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1208047 · Cited by 82
Metabolism and the leukemic stem cell
Abdel-Wahab, O. I., & Levine, R. L. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100523 · Cited by 81
Ahn, G., Botting, K. J., Patterson, A. V., Ware, D. C., Tercel, M., & Wilson, W. R. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.007 · Cited by 81
Porter, J. B., Rafique, R., Srichairatanakool, S., Davis, B. A., Shah, F., HAIR, T., & Evans, P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.018 · Cited by 80
Oxygen-derived free-radical and active oxygen complex formation from cobalt(II) chelates in vitro
Hanna, P. M., Kadiiska, M. B., & Mason, R. P. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00025a019 · Cited by 79
Darinaparsin: a novel organic arsenical with promising anticancer activity
Mann, K. K., Wallner, B., Lossos, I. S., & Miller, W. H. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903282759 · Cited by 78
Pope, L. M., Reich, K. A., Graham, D. R., & Sigman, D. S. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33687-1 · Cited by 77
Diaz, Z., Colombo, M., Mann, K. K., Su, H., Smith, K. N., Bohle, D. S., Schipper, H. M., & Miller, W. H. (2004) · Blood · doi:10.1182/blood-2004-05-1772 · Cited by 77
The interaction of rhodium(II) carboxylates with enzymes.
Howard, R. A., Spring, T. G., & Bear, J. L. (1976) · PubMed · Cited by 76
A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness
Moeller, B. J., Batinic̈‐Haberle, I., Spasojević, I., Rabbani, Z. N., Anscher, M. S., Vujašković, Ž., & Dewhirst, M. W. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.05.026 · Cited by 74
Faure, R. L., Vincent, M., Dufour, M., et al. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590310 · Cited by 70
Cardioprotection by Vanadium Compounds Targeting Akt-Mediated Signaling
Bhuiyan, M. S., & Fukunaga, K. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09r01cr · Cited by 70
Intermolecular disulfide bond to modulate protein function as a redox-sensing switch
Nagahara, N. (2010) · Amino Acids · doi:10.1007/s00726-010-0508-4 · Cited by 69
Jaramillo, M. C., Frye, J. B., Crapo, J. D., Briehl, M. M., & Tome, M. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4031 · Cited by 68
dos Santos, N. A. G., Martins, N. M., Curti, C., Bianchi, M. D. L. P., & dos Santos, A. C. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.07.014 · Cited by 68
Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype
Li, J., Waters, S. B., Drobná, Z., Devesa, V., Stýblo, M., & Thomas, D. J. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.12.002 · Cited by 68
Talbot, S. R., Nelson, R., & Self, W. T. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.161 · Cited by 68
Gold(I) complexes determine apoptosis with limited oxidative stress in Jurkat T cells
Rigobello, M. P., Folda, A., Dani, B., Menabò, R., Scutari, G., & Bindoli, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.026 · Cited by 65
Biochemical effects of binding [(H2O)(NH3)5RuII]2+ to DNA and oxidation to[(NH3)5RuIII]n—DNA.
Clarke, M. J., Jansen, B., Marx, K. A., & Kruger, R. (1986) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)82080-0 · Cited by 65
Gupta, Y., Kohli, D. V., & Jain, S. (2008) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v25.i4.20 · Cited by 63
Manganese Corroles Prevent Intracellular Nitration and Subsequent Death of Insulin-Producing Cells
Okun, Z., Kupershmidt, L., Amit, T., Mandel, S. A., Bar‐Am, O., Youdim, M. B. H., & Gross, Z. (2009) · ACS Chemical Biology · doi:10.1021/cb900159n · Cited by 61
Gregus, Z., & Németi, B. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi158 · Cited by 60
Ruiz-Sánchez, P., König, C., Ferrari, S. M., & Alberto, R. A. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0697-z · Cited by 59
Jaspers, I., Samet, J. M., ERZURUM, S. C., & REED, W. A. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.1.3989 · Cited by 59
Impact of Trivalent Arsenicals on Selenoprotein Synthesis
Ganyc, D., Talbot, S. R., Konate, F., Jackson, S., Schanen, B. C., Cullen, W., & Self, W. T. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9440 · Cited by 56
Kim, N., Oh, M., Park, H., & Kim, I. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09330fp · Cited by 56
Coordinating responses to iron and oxygen stress with DNA and mRNA promoters: The ferritin story
Theil, E. C. (2007) · BioMetals · doi:10.1007/s10534-006-9063-6 · Cited by 55
Hydroxyl Radical Generation in the Nadh/Microsomal Reduction of vanadate
Shi, X., & Dalal, N. S. (1992) · Free Radical Research Communications · doi:10.3109/10715769209083141 · Cited by 55
Majumder, S., Dutta, P., Mookerjee, A., & Choudhuri, S. K. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.10.044 · Cited by 54
Kasprzak, K. S., Zastawny, T. H., North, S. L., Riggs, C. W., Diwan, B. A., Rice, J. M., & Dizdaroğlu, M. (1994) · Chemical Research in Toxicology · doi:10.1021/tx00039a009 · Cited by 54
Custódio, J. B. A., Cardoso, C. M. P., Santos, M. S., Almeida, L. M., Vicente, J. A. F., & Fernandes, M. A. S. (2009) · Toxicology · doi:10.1016/j.tox.2009.01.022 · Cited by 54
Yang, M., Kroft, S. H., & Chitambar, C. R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0557 · Cited by 53
Rébillard, A., Jouan-Lanhouet, S., Jouan, E., Legembre, P., Pizon, M., Sergent, O., Gilot, D., Tekpli, X., Lagadic‐Gossmann, D., & Dimanche‐Boitrel, M. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.01.034 · Cited by 52
Smith, P. F., Hoke, G. D., Alberts, D. W., Bugelski, P. J., Lupo, S., Mirabelli, C. K., & Rush, G. F. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23520-0 · Cited by 51
Inherited disorders of cobalamin metabolism
Qureshi, A. A., Rosenblatt, D. S., & Cooper, B. A. (1994) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)90022-1 · Cited by 48
Timerbaev, A. R., Foteeva, L. S., Rudnev, A. V., Abramski, J. K., Pawlak, K., Hartinger, C. G., Jarosz, M., & Keppler, B. K. (2007) · Electrophoresis · doi:10.1002/elps.200600707 · Cited by 47
Self-citationPaul, M. K., Kumar, R., & Mukhopadhyay, A. K. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.09.020 · Cited by 47
Cellular uptake and distribution of cobalt complexes of fluorescent ligands
Yamamoto, N., Danos, S., Bonnitcha, P., Failes, T. W., New, E. J., & Hambley, T. W. (2008) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-008-0374-7 · Cited by 47
Tian, C., Gao, P., Zheng, Y., Yue, W., Wang, X., Jin, H., & Chen, Q. (2007) · Cell Research · doi:10.1038/cr.2007.112 · Cited by 46
DNA Cleavage by Photogenerated Rh2(O2CCH3)4(H2O)2+
Fu, P. K. ‐., Bradley, P. M., & Turró, C. (2001) · Inorganic Chemistry · doi:10.1021/ic010118w · Cited by 46
Matulis, S. M., Morales, A. A., Yehiayan, L., Croutch, C. R., Gutman, D. M., Cai, Y. Z., Lee, K. P., & Boise, L. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1072 · Cited by 46
Intracellular glutathione and cytotoxicity of platinum complexes
Pendyala, L., Creaven, P. J., Perez, R. P., Zdanowicz, J., & Raghavan, D. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689042 · Cited by 45
Morales, A. A., Gutman, D. M., Cejas, P. J., Lee, K. P., & Boise, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806546200 · Cited by 45
Flavoenzymes reduce vanadium(V) and molecular oxygen and generate hydroxyl radical
Shi, X., & Dalal, N. S. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90423-g · Cited by 45
Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues.
Scrivens, P. J., Alaoui‐Jamali, M. A., Giannini, G., Wang, T., Loignon, M., Batist, G., & Sandor, V. A. (2003) · PubMed · Cited by 45
El-Naggar, M. M., El-Waseef, A., El-Halafawy, K. M., & Elsayed, I. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00213-4 · Cited by 44
Milbank, J. B. J., Stevenson, R. J., Ware, D. C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9008746 · Cited by 43
A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors
Tsimberidou, A. M., Camacho, L. H., Verstovšek, S., Ng, C. S., Hong, D. S., Uehara, C., Gutierrez, C., Daring, S., Stevens, J., Komarnitsky, P. B., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2984 · Cited by 43
Metabolism of the Tumor Angiogenesis Inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous Acid
Dilda, P. J., Ramsay, E. E., Corti, A., Alfonso Pompella, C., & Hogg, P. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804470200 · Cited by 43
Ahmadi, R., Urig, S., Hartmann, M., Helmke, B. M., Končarević, S., Allenberger, B., Kienhoefer, C., Neher, M., Steiner, H. H., Unterberg, A. W., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.09.031 · Cited by 42
Ahn, G., Ware, D. C., Denny, W. A., & Wilson, W. R. (2004) · Radiation Research · doi:10.1667/rr3229 · Cited by 42
Cascales, M., Martín‐Sanz, P., Craciunescu, D. G., Mayo, I., Aguilar, A., Robles-Chillida, E. M., & Cascales, C. (1991) · Carcinogenesis · doi:10.1093/carcin/12.2.233 · Cited by 40
Arsenite medicinal use, metabolism, pharmacokinetics and monitoring in human hair
Nicolis, I., Curis, E., Deschamps, P., & Bénazeth, S. (2009) · Biochimie · doi:10.1016/j.biochi.2009.06.003 · Cited by 38
On the question of a carcinogenic action of cobaltcontaining compounds
Steinhoff, D., & Möhr, U. (1991) · Experimental Pathology · doi:10.1016/s0232-1513(11)80084-8 · Cited by 37
Bowling, B. D., Doudican, N. A., Manga, P., & Orlow, S. J. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0705-y · Cited by 36
Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma
Jiang, H., Ma, Y., Chen, X., Pan, S., Sun, B., Krissansen, G. W., & Sun, X. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01464.x · Cited by 36
Bencini, A., Failli, P., Valtancoli, B., & Bani, D. (2010) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152510791698389 · Cited by 35
Arsenic trioxide induces endoplasmic reticulum stress-related events in neutrophils
Binet, F., Chiasson, S., & Girard, D. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.01.013 · Cited by 35
江島, 邦., Layne, M. D., Carvajal, I. M., Nanri, H., Ith, B., Yet, S., & Perrella, M. A. (2002) · Antioxidants and Redox Signaling · doi:10.1089/15230860260220067 · Cited by 33
Oxidation-reduction reactions in Ehrlich cells treated with copper-neocuproine
Byrnes, R. W., Antholine, W. E., & Petering, D. H. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90141-3 · Cited by 33
The metal-responsive transcription factor-1 protein is elevated in human tumors
Shi, Y. H., Amin, K., Sato, B., Samuelsson, S. J., Sambucetti, L. C., Haroon, Z. A., Laderoute, K. R., & Murphy, B. J. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.6.10979 · Cited by 33
Bauer, J. A., Lupica, J. A., Szugye, H., Morrison, B., Haney, R. M., Masci, R. K., Lee, R. M., DiDonato, J. A., & Lindner, D. J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001313 · Cited by 29
Yangyuoru, P. M., Webb, J. W., & Shaw, C. F. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.10.028 · Cited by 27
Heffeter, P., Popović-Bijelić, A. D., Saiko, P., Dornetshuber, R., Jungwirth, U., Voevodskaya, N. V., Biglino, D., Jakupec, M. A., Elbling, L., Micksche, M., et al. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909789056962 · Cited by 24
Self-citationNaura, A. S., & Sharma, R. P. (2009) · Drug and Chemical Toxicology · doi:10.1080/01480540902882234 · Cited by 22
As(III) transcriptionally activates the gadd45a gene via the formation of H2O2
Bower, J. J., Leonard, S. S., Chen, F., & Shi, X. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.04.007 · Cited by 21
Selective Induction of Liver Parenchymal Cell Heme Oxygenase-1 in Selenium-Deficient Rats
Mostert, V., Hill, K. E., Ferris, C. D., & Burk, R. F. (2003) · Biological Chemistry · doi:10.1515/bc.2003.076 · Cited by 21
The mechanism of acute cytotoxicity of triethylphosphine gold(I) complexes
Hoke, G. D., Rush, G. F., & Mirabelli, C. K. (1989) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(89)90110-5 · Cited by 20
Golemović, M., Quintás‐Cardama, A., Manshouri, T., Oršolić, N., Duzkale, H., Johansen, M. J., Freireich, E. J., Kantarjian, H. M., Zingaro, R. A., & Verstovšek, S. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9267-z · Cited by 17
Jakimowicz, P., Ostropolska, Ł., & Pruchnik, F. P. (2000) · Metal-Based Drugs · doi:10.1155/mbd.2000.201 · Cited by 17
Giommarelli, C., Corti, A., Supino, R., Favini, E., Paolicchi, A., Alfonso Pompella, C., & Zunino, F. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.006 · Cited by 16
Sava, G., Zorzet, S., Mestroni, G., & Zassinovich, G. (1985) · PubMed · Cited by 16
Redox-active cobalt complexes as promising antitumor agents
Osinsky, S., Levitin, I. Y., Sigan, A. L., Bubnovskaya, L., Ganusevich, І. І., Campanella, L., & Wardman, P. (2003) · Russian Chemical Bulletin · doi:10.1023/b:rucb.0000019880.29941.77 · Cited by 15
Nocentini, G., & Barzi, A. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00139-6 · Cited by 12
Cited by
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
Metal complexes in cancer therapy – an update from drug design perspective
Ndagi, U., Mhlongo, N., & Soliman, M. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s119488 · Cited by 935
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Trondl, R., Heffeter, P., Kowol, C. R., Jakupec, M. A., Berger, W., & Keppler, B. K. (2014) · Chem. Sci. · doi:10.1039/c3sc53243g · Cited by 675
Self-citationNext-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Metadata
- Authors
- Jungwirth, U., Kowol, C. R., Keppler, B. K., Hartinger, C. G., Berger, W., & Heffeter, P.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2011-08-15
- Volume
- 15
- Issue
- 4
- Pages
- 1085-1127
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W1985233650
- Cited by
- 554
- References
- 316
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.